These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21145816)

  • 1. Evaluation of combination therapy against hepatitis C virus infection in human liver chimeric mice.
    de Jong YP; Rice CM; Ploss A
    J Hepatol; 2011 May; 54(5):848-50. PubMed ID: 21145816
    [No Abstract]   [Full Text] [Related]  

  • 2. [Daclatasvir-sofosbuvir combination therapy for chronic hepatitis C virus infection: progress in clinical studies].
    Lu J; Zhou HJ; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):147-150. PubMed ID: 29804384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic answers to complicated questions for the course of chronic hepatitis C treatment.
    Örmeci N; Erdem H
    Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):371-82. PubMed ID: 22646258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy for hepatitis C virus reinfection after orthoptic liver transplantation.
    Israeli E; Galun E; Eid A; Ilan Y; Ashur Y; Jurim O; Bishara A; Safadi R
    Transplant Proc; 2001 Sep; 33(6):2929. PubMed ID: 11543793
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic hepatitis C virus infection: always treat!--Contra].
    Blum HE
    Dtsch Med Wochenschr; 2002 Sep; 127(36):1841. PubMed ID: 12215932
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness and safety of direct-acting antiviral agents for treatment of patients with chronic hepatitis C virus infection].
    Yang J; Rao HY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Mar; 26(3):175-178. PubMed ID: 29804389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preface. Hepatitis C infection.
    Janssen H; Craxi A
    Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):369. PubMed ID: 23199496
    [No Abstract]   [Full Text] [Related]  

  • 9. [Management of chronic hepatitis C infection in patients infected with the human immunodeficiency virus: from what we know to what we ignore].
    Torre-Cisneros J; Rivero A
    Med Clin (Barc); 2001 Jun; 116(20):775-8. PubMed ID: 11440683
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of chronic viral hepatitis.
    Main J; McCarron B; Thomas HC
    Antivir Chem Chemother; 1998 Nov; 9(6):449-60. PubMed ID: 9865383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the treatment of chronic hepatitis C virus infection: a case series from a hospital in the Brazilian Amazon region.
    Amaral Ido S; Quaresma JA; Miranda EC; Móia Lde J; Soares Mdo C
    Braz J Infect Dis; 2014; 18(2):233-4. PubMed ID: 24513483
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcome of combination antiviral therapy in hepatitis C virus infected patients with sickle cell disease.
    Alavian SM; Tabatabaei SV; Ayyub M
    Saudi Med J; 2009 Aug; 30(8):1107-8; author reply 1107-8. PubMed ID: 19668900
    [No Abstract]   [Full Text] [Related]  

  • 13. Current status of antiviral therapy for chronic hepatitis C.
    Lemon SM
    Adv Exp Med Biol; 1999; 458():29-37. PubMed ID: 10549377
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of recurrent hepatitis C following liver transplantation.
    Bizollon T; Ducerf C; Baulieux J; Trepo C
    Curr Gastroenterol Rep; 1999; 1(1):15-9. PubMed ID: 10980921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness and safety of sofosbuvir+daclatasvir in the treatment of chronic hepatitis C virus infection in Yan'an, Shaanxi].
    Gao XH; Jing P
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jun; 27(6):457-459. PubMed ID: 31357763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy for hepatitis C infection.
    Liang TJ
    N Engl J Med; 1998 Nov; 339(21):1549-50. PubMed ID: 9819457
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis C virus experimental model systems and antiviral drug research.
    Uprichard SL
    Virol Sin; 2010 Aug; 25(4):227-45. PubMed ID: 20960298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of chronic hepatitis B and C - update 2010].
    Mertens JC; Geier A; Müllhaupt B
    Praxis (Bern 1994); 2010 Aug; 99(17):1015-28. PubMed ID: 20737393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of antiviral effect of type I, II, and III interferons on direct-acting antiviral-resistant hepatitis C virus.
    Hamana A; Takahashi Y; Uchida T; Nishikawa M; Imamura M; Chayama K; Takakura Y
    Antiviral Res; 2017 Oct; 146():130-138. PubMed ID: 28864074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rising relapse rate in hepatitis C virus type 3a-infected patients against sofosbuvir and ribavirin combination therapy: a Pakistani experience.
    Wahid B; Saleem K; Ali A; Rafique S; Idrees M
    Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):979-980. PubMed ID: 28471832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.